BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 4:18:23 PM | Browse: 14 | Download: 65
 |
Received |
|
2024-10-06 15:04 |
|
Peer-Review Started |
|
2024-10-06 15:04 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-12-27 01:40 |
|
Revised |
|
2025-01-08 15:50 |
|
Second Decision |
|
2025-01-21 02:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-01-21 07:56 |
|
Articles in Press |
|
2025-01-21 07:56 |
|
Publication Fee Transferred |
|
2025-01-13 12:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-03-05 08:30 |
|
Publish the Manuscript Online |
|
2025-03-25 16:18 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing Fei, Li-Wen Qi, Yuan Liu, Min Shu and Wen-Qiang Mo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jing Fei, Department of Oncology, The First Affiliated Hospital of Shihezi University, No. 107 North Second Road, Shihezi 832008, Xinjiang Uygur Autonomous Region, China. feij_xj@163.com |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; Radiofrequency ablation; Survival analysis; Multimodal therapy; Locoregional therapy; Synergistic effects |
| Core Tip |
Our study addresses a critical aspect of hepatocellular carcinoma (HCC) treatment, comparing the outcomes of transarterial chemoembolization (TACE) alone vs the combination of TACE with percutaneous radiofrequency ablation. With a robust retrospective analysis of 106 patients, our findings highlight significant enhancements in treatment efficacy and survival rates when these therapies are combined, thus proposing a pivotal shift in therapeutic strategies for patients with unresectable HCC. |
| Publish Date |
2025-03-25 16:18 |
| Citation |
<p>Fei J, Qi LW, Liu Y, Shu M, Mo WQ. Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment. <i>World J Gastrointest Oncol</i> 2025; 17(4): 102038</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i4/102038.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i4.102038 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
